Human Longevity Stock
Genomics and cell therapy
Sign up today and learn more about Human Longevity Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Human Longevity Stock
Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. HLI’s business areas include the HLI Health Nucleus, a genomic powered clinical research center which uses whole genome sequence analysis, advanced clinical imaging and innovative machine learning, along with curated personal health information, to deliver the most complete picture of individual health; HLIQ™ Whole Genome and HLIQ Oncology.
Investors
DFJ Growth
Commonwealth Fusion, Avant, Hopin, DataRobot, Unity Technologies, Cohesity, Collective Health, Sysdig, Mapbox, Alchemy
GE Ventures
View, Pivotal, Virgin Hyperloop One, Omada Health, Desktop Metal, Catalant, Rethink Robotics, Vineti, Syapse, Tamr
OS Fund
Pivot Bio, Emulate, Tempo Automation, Human Longevity, Verge Genomics, Elysium Health, uBiome, 3T Biosciences
StartUp Health
Devoted Health, Cityblock Health, Virta Health, Human Longevity
Amino Capital
Chime, Weee!, Webflow, Wyze Labs, DFINITY, Human Longevity, Voyage, OneChronos
Funding History
June 2019 | $36.4M |
---|---|
June 2019 | $18.0M |
Management
Co-Founder & CEO
J. Venter
Co-Founder & Vice Chairman
Robert Hariri
Chief Information Officer
Yaron Turpaz
Medical Director
Brad Perkins
Press
genengnews - Feb, 1 2024
Human Longevity Spin-Out Aims to Tap into Variant Interpretation Marketnews - Dec, 14 2023
From Longevity To Aging In Place, These Are The Top Areas For Senior-Focused Startupsspannr - Oct, 9 2022
$1 Billion Public Listing For Human Longevity Has Been Called Offspannr - Aug, 13 2022
Human Longevity To Go Public Through SPAC at $1 Billion Valuationfiercebiotech - Jun, 22 2022
Human Longevity seeks new life with proposed SPAC deal